Connection

Maria Lopes-Virella to Uracil

Back to Details
This is a "connection" page, showing publications Maria Lopes-Virella has written about Uracil.
Maria Lopes-Virella
Connection Strength
0.180
Uracil
  1. DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice. J Cardiovasc Pharmacol. 2011 Aug; 58(2):157-66.
    View in: PubMed
    Score: 0.093
  2. DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes. Atherosclerosis. 2010 Dec; 213(2):429-35.
    View in: PubMed
    Score: 0.087
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.